Clinical trial
Inherited Genetic Susceptibility in Langerhans Cell Histiocytosis (LCH)
NCT04100408 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Inherited Genetic Susceptibility in Langerhans Cell Histiocytosis (LCH)
- Lead sponsor
- Children's Oncology Group
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- June 1, 2020
- Completion date
- September 30, 2026
- Enrollment
- 647 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.